|
Pluses and minuses
The Newark Advocate Baum was in stage five renal failure prior to successful transplant surgery one week ago. Both patients are recovering nicely, and doctors say Baum’s new kidney already is working. • Minus: Squabbles about a Bowling Green Township trustee’s insistence … |
FDA Approves Merck's NOXAFIL(R) (posaconazole) Injection (18 mg/mL) for … – Wall Street Journal
|
FDA Approves Merck’s NOXAFIL(R) (posaconazole) Injection (18 mg/mL) for …
Wall Street Journal The administration of NOXAFIL with sirolimus, pimozide, quinidine, atorvastatin, lovastatin, simvastatin and ergot alkaloids must be avoided. When administered with NOXAFIL, some drugs such as cyclosporine and tacrolimus required dosage adjustments … |
FDA Approves Merck's NOXAFIL® (posaconazole) Injection (18 mg/mL) for … – MarketWatch
Drug Discovery & Development |
FDA Approves Merck’s NOXAFIL® (posaconazole) Injection (18 mg/mL) for …
MarketWatch The administration of NOXAFIL with sirolimus, pimozide, quinidine,atorvastatin, lovastatin, simvastatin and ergot alkaloids must be avoided. When administered with NOXAFIL, some drugs such as cyclosporine and tacrolimus required dosage adjustments and … FDA Approves Merck’s NOXAFIL(R) (posaconazole) Injection (18 mg/mL) for …Wall Street Journal |
FDA Approves Merck's NOXAFIL ® (posaconazole) Injection (18 mg/mL) for … – Business Wire (press release)
|
FDA Approves Merck’s NOXAFIL ® (posaconazole) Injection (18 mg/mL) for …
Business Wire (press release) The administration of NOXAFIL with sirolimus, pimozide, quinidine, atorvastatin, lovastatin, simvastatin and ergot alkaloids must be avoided. When administered with NOXAFIL, some drugs such as cyclosporine and tacrolimus required dosage adjustments … |
'Keep thinking of the future': Chimp attack victim fights for her day in court – Today.com
|
‘Keep thinking of the future’: Chimp attack victim fights for her day in court
Today.com She had a successful hand transplant at the time of the face transplant surgery. But when she developed pneumonia, her doctors had to remove the transplanted hands because of the infection and poor circulation. “So it’s like I lost my hands twice … |
Bladder Cancer Patient on Everolimus Has Complete Response – Cancer Network
Cancer Network |
Bladder Cancer Patient on Everolimus Has Complete Response
Cancer Network In a phase I trial, a bladder cancer patient has had a 14-month complete response with the combination of the mTOR inhibitor everolimus and pazopanib, a selective multi-targeted receptor tyrosine kinase inhibitor that targets angiogenesis, including … Patient with advanced bladder cancer shows complete response to everolimus …News-Medical.net Exceptional Responder Provides Treatment Clues in Bladder CancerOncLive Genomic testing links ‘exceptional’ drug response to rare mutations in bladder …EurekAlert (press release) |
Italy, Napoli fullback Maggio has collapsed lung – Times of India
Italy, Napoli fullback Maggio has collapsed lungTimes of IndiaNAPLES: Italy and Napoli fullback Christian Maggio has been hospitalized with a collapsed lung after getting hit in the chest earlier this week in training. Napoli says Maggio was taken to a…
Biosimilar Monoclonal Antibodies Emerge From The Pipeline On Both Sides Of … – Mondaq News Alerts (registration)
|
Biosimilar Monoclonal Antibodies Emerge From The Pipeline On Both Sides Of …
Mondaq News Alerts (registration) The European Medicines Agency (“EMEA”) made its biosimilar monoclonal antibody guidelines effective in December 20121. Less than a year later, in September 2013, it approved Europe’s first biosimilar antibody. The drug is Inflectra which is a … |
Call for More Focus on HF in Diabetes Trials – MedPage Today
The Information Daily |
Call for More Focus on HF in Diabetes Trials
MedPage Today Many such trials don’t include heart failure as an endpoint, which is a problem because hospitalizations for the condition are commonly seen in patients with diabetes, according to John McMurray, MD, of the University of Glasgow in Scotland, and … Heart risks of diabetes drugs not properly assessed, says expertThe Information Daily Heart risks of glucose-lowering drugs being overlooked in clinical trialsHealthCanal.com Risk of heart problems from antidiabetes drugs is being overlooked, experts warnthejournal.ie |
Miss. governor signs organ donation law – Knoe.com
|
Miss. governor signs organ donation law
Knoe.com JACKSON, Miss. (KNOE 8 News/AP) – Gov. Phil Bryant has signed a bill that removes the repealer from Mississippi’s organ donor law. The repealer required the Mississippi Legislature to periodically review the program and renew it. Senate Bill 2217 … |